In a groundbreaking announcement, the FDA has unveiled plans to phase out animal testing requirements for monoclonal antibodies and other drugs, opting instead for modern, humane methods like AI modeling, human organ-on-chip technology, and real-world human data. This decision represents significant progress for animal welfare, scientific innovation, and patient safety—and it’s exactly the type of change NAVS supporters have helped make possible.